A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can ...

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.

Exagen Inc. has announced conditional approval from the New York State Department of Health for its innovative new biomarker ...

A new study investigates the role of Krüppel-like factor 2 (KLF2, a protein coding gene involved in a variety of regulatory ...

Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people ...

IGM Biosciences announced the discontinuation of imvotamab and IGM-2644 for autoimmune and inflammatory diseases, including lupus.

In a new study published in Lupus Science & Medicine, researchers reviewed randomized clinical trials (RCTs) to assess therapies for initial management of lupus nephritis (LN), focusing on their ...

In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of ...

The Lupus Foundation of America uses an electronic grant submission process. All applicants must submit their full application packages through the ProposalCentral online grants management system.

The Patient-Physician Dialogue Tool (PDF) is a guide to support people going through the process of diagnosis. It includes a checklist and some pointers on questions to ask to make the most of your ...

There is no easy way to describe Nick Cannon, 32. To say he is a man of multiple talents is an understatement. He’s a successful actor, radio and television personality, comedian, songwriter-rapper, ...

Whether or not you have lupus, exercise is an important way to take care of yourself. Exercise has many physical, emotional and social benefits. It is particularly helpful for people with lupus, and ...